Glaukos Corp Files 8-K with Exhibits
Ticker: GKOS · Form: 8-K · Filed: May 14, 2025 · CIK: 1192448
Sentiment: neutral
Topics: regulatory-filing, exhibits
Related Tickers: GKOS
TL;DR
Glaukos filed a routine 8-K with exhibits, no major news.
AI Summary
Glaukos Corporation filed an 8-K on May 14, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or new material events beyond the standard reporting of exhibits and disclosures.
Why It Matters
This 8-K filing indicates Glaukos Corporation is providing standard disclosures and exhibits to the SEC, which is a routine regulatory requirement.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report of exhibits and disclosures, not indicating any new material risks or events.
Key Players & Entities
- Glaukos Corporation (company) — Registrant
- May 14, 2025 (date) — Date of Report
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to provide Financial Statements and Exhibits.
What is the filing date of this 8-K report?
The filing date of this 8-K report is May 14, 2025.
What is the principal executive office address for Glaukos Corporation?
The principal executive office address for Glaukos Corporation is One Glaukos Way, Aliso Viejo, California, 92656.
What is the telephone number for Glaukos Corporation?
The telephone number for Glaukos Corporation is (949) 367-9600.
What is the SIC code for Glaukos Corporation?
The Standard Industrial Classification (SIC) code for Glaukos Corporation is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 14, 2025 regarding GLAUKOS Corp (GKOS).